date,title,source
Oct-23-18,Provention Bio Announces Completion of Enrollment of Phase 1b Clinical Trial of PRV-300 in Moderate-to-Severe Ulcerative Colitis,PR Newswire
Nov-05-18,Amgen And Provention Bio Announce Co-Development Collaboration In Celiac Disease,PR Newswire
Nov-08-18,Provention Bio Reports Third Quarter 2018 Financial Results and Provides Business Update,PR Newswire
Nov-28-18,Provention Bio Joins the C-Path Type 1 Diabetes (T1D) Consortium,PR Newswire
Dec-25-18,"Are Insiders Buying Provention Bio, Inc. (NASDAQ:PRVB) Stock?",Simply Wall St.
